Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
- Written by PR Newswire
![]() |
- Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters
- Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support
- Plans further investments to add capabilities and strengthen long-term operations at the Rockville site
INCHEON, South Korea...















